Making gene editing a therapeutic reality

This review discusses current bottlenecks in making CRISPR-Cas9-mediated genome editing a therapeutic reality and it outlines recent strategies that aim to overcome these hurdles as well as the scope of current clinical trials that pioneer the medical translation of CRISPR-Cas9. Additionally, this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Conboy, Irina, Murthy, Niren, Etienne, Jessy, Robinson, Zachery
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305220/
https://www.ncbi.nlm.nih.gov/pubmed/30613384
http://dx.doi.org/10.12688/f1000research.16106.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305220/
https://www.ncbi.nlm.nih.gov/pubmed/30613384
http://dx.doi.org/10.12688/f1000research.16106.1

Ejemplares similares